HIV

3rd European Chemsex Forum

Paris, France,

The 3rd European Chemsex Forum will be a 2½ day, multi-disciplinary event, in Paris, 14-16 November 2019.

Activities include an evening opening with keynote speeches on Thursday, the Data and Evidence Day on Friday, and the Community Mobilisation Day on Saturday.

17th European AIDS Conference

Basl,

Basel is the host of the 17th European AIDS Conference, taking place from November 6-9, 2019.

Be part of the largest European HIV conference this year, to learn about the latest scientific updates, new challenges, best practices and much more.

9th International Workshop on HIV Persistence during Therapy

Miami, United States,

The 9th International Workshop on HIV Persistence during Therapy will be held in Miami, from December 10-13, 2019.

It is the only scientific event tackling the topics of HIV Persistence, HIV Reservoirs and HIV Cure that attracts, every 2 years, VIPs and young investigators. Its quality increases at each edition, with more and more fresh data not yet shown elsewhere nor published.

Abstract topics:

INTEREST Workshop

Accra, Ghana,

Known as the “African CROI” the INTEREST Conference brings together scientists involved in HIV treatment, pathogenesis, and prevention research in Africa to share pivotal findings, promote collaboration, and transfer experiences across several fields and many continents.

HIV Knowledge and Risk Behaviors among Drug Users in Three Vietnamese Mountainous Provinces

Citation
Nguyen et al. Substance Abuse Treatment, Prevention, and Policy (2019) 14:3 https://doi.org/10.1186/s13011-019-0191-8
Publication Date

Abstract

Background

Globally, people who inject drugs are highly vulnerable to HIV transmission. Methadone maintenance treatment (MMT) programs are one of the most cost-effective mechanisms to substitute opioid use and improve the quality of life of patients.

HepHIV2019 Conference

Bucharest, Romania,

The HepHIV2019 conference, which is organised jointly with the 3-year EU funded joint action INTEGRATE, will take place 28-30 January 2019 in Bucharest, Romania.

Inactivation of HCV and HIV by Microwave: A Novel Approach for Prevention of Virus Transmission among People who Inject Drugs

Citation
Siddharta, A. et al. Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugs. Sci. Rep. 6, 36619; doi: 10.1038/srep36619 (2016).
Publication Date

Abstract

Hepatitis C virus (HCV) and human immunodeficiency virus (HIV-1) transmissions among people who inject drugs (PWID) continue to pose a challenging global health problem. Here, we aimed to analyse a universally applicable inactivation procedure, namely microwave irradiation, as a safe and effective method to reduce the risk of viral transmission.

The Effect of Public Health-Oriented Drug Law Reform on HIV Incidence in People who Inject Drugs in Tijuana, Mexico

Citation
Borquez, A., Beletsky, L., Nosyk, B., Strathdee, S. A., Madrazo, A., Abramovitz, D., . . . Martin, N. K. (2018). The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: An epidemic modelling study. The Lancet Public Health, 3(9). doi:10.1016/s2468-2667(18)30097-5
Publication Date

Summary

Background

As countries embark on public health-oriented drug law reform, health impact evaluations are needed. In 2012, Mexico mandated the narcomenudeo reform, which depenalised the possession of small amounts of drugs and instituted drug treatment instead of incarceration.